Herbert Silva

Herbert Silva is an experienced professional in the fields of oncology and hematology, currently serving as the Oncology & Hematology Business Unit Director at Blanver since July 2016, overseeing strategic alliances, licensing, and product portfolio management. Prior to this role, Herbert held various significant positions, including National Sales Manager at Bristol-Myers Squibb, where Herbert was instrumental in the successful launch of Yervoy® in Brazil, and Business Unit Head at Hetero Drugs Ltd. Herbert's career also includes leadership roles at Dr. Reddy's Laboratories and Schering-Plough, alongside early career experience in pharmaceutical sales at Boehringer Ingelheim and IT management at Predileto Pena Branca. Educational qualifications include an MBA in Marketing from FGV and a Program for Management Development from IESE Business School.